RB1 and glioblastoma: The Cancer Genome Atlas Research Network (TCGA) revealed in 2008 that the cycD1-CDK4/6-Rb1 pathway is, with alterations in 78.9% of glioblastoma, among the top three most altered pathways (29, 30).